{"id":444904,"date":"2024-12-06T11:31:37","date_gmt":"2024-12-06T17:31:37","guid":{"rendered":"https:\/\/billieparkernoticias.com\/?p=444904"},"modified":"2024-12-06T11:31:37","modified_gmt":"2024-12-06T17:31:37","slug":"cofepris-autoriza-tratamiento-innovador-para-pacientes-con-alzheimer","status":"publish","type":"post","link":"https:\/\/fronteraveracruz.com\/?p=444904","title":{"rendered":"Cofepris autoriza tratamiento innovador para pacientes con Alzheimer-"},"content":{"rendered":"<ul>\n<li><strong>El pasado 26 de noviembre se autoriz\u00f3 Lecanemab se trata de un medicamento biotecnol\u00f3gico innovador que ayuda a reducir la tasa de progresi\u00f3n de la enfermedad y a retardar el deterioro cognitivo y funcional.<\/strong><\/li>\n<li><strong>M\u00e1s de un mill\u00f3n de personas en M\u00e9xico padecen esta enfermedad que afecta principalmente a adultos mayores de 65 a\u00f1os.<\/strong><\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p>06.12.2024.- Ciudad de M\u00e9xico.- La Comisi\u00f3n Federal para la Protecci\u00f3n contra Riesgos Sanitarios (Cofepris) el pasado 26 de noviembre aprob\u00f3, el registro sanitario de lecanemab \u00a0medicamento biotecnol\u00f3gico innovador para el tratamiento de Alzheimer.<\/p>\n<p>Este medicamento, est\u00e1 indicado para pacientes diagnosticados en etapa temprana de la enfermedad, en la cual pueden desenvolverse de manera independiente, pero manifiestan episodios de p\u00e9rdida de memoria, como olvidar palabras familiares o la ubicaci\u00f3n de objetos cotidianos.<\/p>\n<p>Las personas con Alzheimer suelen olvidar eventos recientes y presentar problemas de lenguaje, alteraciones del pensamiento abstracto, desorientaci\u00f3n, cambios en el estado de \u00e1nimo, p\u00e9rdida de habilidades previamente adquiridas, como manejar, no recordar lugares habituales o nombres de personas cercanas, as\u00ed como vestirse por s\u00ed mismas, entre otras caracter\u00edsticas.<\/p>\n<p>En fases terminales es posible que quienes sufren este padecimiento presenten dificultades al ingerir alimentos, caminar, hablar, as\u00ed como de incontinencia fecal y urinaria.<\/p>\n<p>De acuerdo con la Secretar\u00eda de Salud, en M\u00e9xico aproximadamente un mill\u00f3n 300 mil personas padecen Alzheimer, esta cifra representa entre 60 y 70 por ciento de los diagn\u00f3sticos de demencia y con mayor frecuencia afecta a personas mayores de 65 a\u00f1os.<\/p>\n<p>En el mundo, seg\u00fan cifras de la Organizaci\u00f3n Mundial de la Salud (OMS) cerca de 60 millones de personas viven con esta enfermedad.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>El pasado 26 de noviembre se autoriz\u00f3 Lecanemab se trata de un medicamento biotecnol\u00f3gico innovador que ayuda a reducir la tasa de progresi\u00f3n de la enfermedad y a retardar el deterioro cognitivo y funcional. M\u00e1s de un mill\u00f3n de personas en M\u00e9xico padecen esta enfermedad que afecta principalmente a adultos mayores de 65 a\u00f1os. &nbsp;&#8230;<\/p>\n","protected":false},"author":1,"featured_media":444909,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_kad_post_transparent":"","_kad_post_title":"","_kad_post_layout":"","_kad_post_sidebar_id":"","_kad_post_content_style":"","_kad_post_vertical_padding":"","_kad_post_feature":"","_kad_post_feature_position":"","_kad_post_header":false,"_kad_post_footer":false,"_kad_post_classname":"","footnotes":""},"categories":[18,229],"tags":[2174,5932],"class_list":["post-444904","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-noticias-de-ultima-hora","category-salud","tag-alzheimer","tag-lecanemab"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Cofepris autoriza tratamiento innovador para pacientes con Alzheimer- Frontera Veracruz<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/fronteraveracruz.com\/?p=444904\" \/>\n<meta property=\"og:locale\" content=\"es_MX\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cofepris autoriza tratamiento innovador para pacientes con Alzheimer- Frontera Veracruz\" \/>\n<meta property=\"og:description\" content=\"El pasado 26 de noviembre se autoriz\u00f3 Lecanemab se trata de un medicamento biotecnol\u00f3gico innovador que ayuda a reducir la tasa de progresi\u00f3n de la enfermedad y a retardar el deterioro cognitivo y funcional. M\u00e1s de un mill\u00f3n de personas en M\u00e9xico padecen esta enfermedad que afecta principalmente a adultos mayores de 65 a\u00f1os. &nbsp;...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/fronteraveracruz.com\/?p=444904\" \/>\n<meta property=\"og:site_name\" content=\"Frontera Veracruz\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/share\/1CtNrbq7Bz\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-12-06T17:31:37+00:00\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/fronteraveracruz.com\\\/?p=444904#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/fronteraveracruz.com\\\/?p=444904\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\\\/\\\/fronteraveracruz.com\\\/#\\\/schema\\\/person\\\/bcc4f8719847e210f67a9030f3486609\"},\"headline\":\"Cofepris autoriza tratamiento innovador para pacientes con Alzheimer-\",\"datePublished\":\"2024-12-06T17:31:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/fronteraveracruz.com\\\/?p=444904\"},\"wordCount\":287,\"publisher\":{\"@id\":\"https:\\\/\\\/fronteraveracruz.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/fronteraveracruz.com\\\/?p=444904#primaryimage\"},\"thumbnailUrl\":\"\",\"keywords\":[\"Alzheimer\",\"lecanemab\"],\"articleSection\":[\"Noticias de \u00faltima hora\",\"Salud\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/fronteraveracruz.com\\\/?p=444904\",\"url\":\"https:\\\/\\\/fronteraveracruz.com\\\/?p=444904\",\"name\":\"Cofepris autoriza tratamiento innovador para pacientes con Alzheimer- Frontera Veracruz\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/fronteraveracruz.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/fronteraveracruz.com\\\/?p=444904#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/fronteraveracruz.com\\\/?p=444904#primaryimage\"},\"thumbnailUrl\":\"\",\"datePublished\":\"2024-12-06T17:31:37+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/fronteraveracruz.com\\\/?p=444904#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/fronteraveracruz.com\\\/?p=444904\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/fronteraveracruz.com\\\/?p=444904#primaryimage\",\"url\":\"\",\"contentUrl\":\"\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/fronteraveracruz.com\\\/?p=444904#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inicio\",\"item\":\"https:\\\/\\\/fronteraveracruz.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cofepris autoriza tratamiento innovador para pacientes con Alzheimer-\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/fronteraveracruz.com\\\/#website\",\"url\":\"https:\\\/\\\/fronteraveracruz.com\\\/\",\"name\":\"Frontera Veracruz\",\"description\":\"Noticias C\u00f3rdoba \u00b7 Orizaba \u00b7 Veracruz\",\"publisher\":{\"@id\":\"https:\\\/\\\/fronteraveracruz.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/fronteraveracruz.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/fronteraveracruz.com\\\/#organization\",\"name\":\"Frontera Veracruz\",\"url\":\"https:\\\/\\\/fronteraveracruz.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/fronteraveracruz.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/fronteraveracruz.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/logo-header.png\",\"contentUrl\":\"https:\\\/\\\/fronteraveracruz.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/logo-header.png\",\"width\":600,\"height\":220,\"caption\":\"Frontera Veracruz\"},\"image\":{\"@id\":\"https:\\\/\\\/fronteraveracruz.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/share\\\/1CtNrbq7Bz\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/fronteraveracruz.com\\\/#\\\/schema\\\/person\\\/bcc4f8719847e210f67a9030f3486609\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ee9bf24b351129017c91674dc617cfdc21c62b9b23a52c046f0b2543ba35355c?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ee9bf24b351129017c91674dc617cfdc21c62b9b23a52c046f0b2543ba35355c?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ee9bf24b351129017c91674dc617cfdc21c62b9b23a52c046f0b2543ba35355c?s=96&d=mm&r=g\",\"caption\":\"admin\"},\"sameAs\":[\"https:\\\/\\\/fronteraveracruz.com\"],\"url\":\"https:\\\/\\\/fronteraveracruz.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cofepris autoriza tratamiento innovador para pacientes con Alzheimer- Frontera Veracruz","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/fronteraveracruz.com\/?p=444904","og_locale":"es_MX","og_type":"article","og_title":"Cofepris autoriza tratamiento innovador para pacientes con Alzheimer- Frontera Veracruz","og_description":"El pasado 26 de noviembre se autoriz\u00f3 Lecanemab se trata de un medicamento biotecnol\u00f3gico innovador que ayuda a reducir la tasa de progresi\u00f3n de la enfermedad y a retardar el deterioro cognitivo y funcional. M\u00e1s de un mill\u00f3n de personas en M\u00e9xico padecen esta enfermedad que afecta principalmente a adultos mayores de 65 a\u00f1os. &nbsp;...","og_url":"https:\/\/fronteraveracruz.com\/?p=444904","og_site_name":"Frontera Veracruz","article_publisher":"https:\/\/www.facebook.com\/share\/1CtNrbq7Bz\/","article_published_time":"2024-12-06T17:31:37+00:00","author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"admin","Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/fronteraveracruz.com\/?p=444904#article","isPartOf":{"@id":"https:\/\/fronteraveracruz.com\/?p=444904"},"author":{"name":"admin","@id":"https:\/\/fronteraveracruz.com\/#\/schema\/person\/bcc4f8719847e210f67a9030f3486609"},"headline":"Cofepris autoriza tratamiento innovador para pacientes con Alzheimer-","datePublished":"2024-12-06T17:31:37+00:00","mainEntityOfPage":{"@id":"https:\/\/fronteraveracruz.com\/?p=444904"},"wordCount":287,"publisher":{"@id":"https:\/\/fronteraveracruz.com\/#organization"},"image":{"@id":"https:\/\/fronteraveracruz.com\/?p=444904#primaryimage"},"thumbnailUrl":"","keywords":["Alzheimer","lecanemab"],"articleSection":["Noticias de \u00faltima hora","Salud"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/fronteraveracruz.com\/?p=444904","url":"https:\/\/fronteraveracruz.com\/?p=444904","name":"Cofepris autoriza tratamiento innovador para pacientes con Alzheimer- Frontera Veracruz","isPartOf":{"@id":"https:\/\/fronteraveracruz.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/fronteraveracruz.com\/?p=444904#primaryimage"},"image":{"@id":"https:\/\/fronteraveracruz.com\/?p=444904#primaryimage"},"thumbnailUrl":"","datePublished":"2024-12-06T17:31:37+00:00","breadcrumb":{"@id":"https:\/\/fronteraveracruz.com\/?p=444904#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/fronteraveracruz.com\/?p=444904"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/fronteraveracruz.com\/?p=444904#primaryimage","url":"","contentUrl":""},{"@type":"BreadcrumbList","@id":"https:\/\/fronteraveracruz.com\/?p=444904#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inicio","item":"https:\/\/fronteraveracruz.com\/"},{"@type":"ListItem","position":2,"name":"Cofepris autoriza tratamiento innovador para pacientes con Alzheimer-"}]},{"@type":"WebSite","@id":"https:\/\/fronteraveracruz.com\/#website","url":"https:\/\/fronteraveracruz.com\/","name":"Frontera Veracruz","description":"Noticias C\u00f3rdoba \u00b7 Orizaba \u00b7 Veracruz","publisher":{"@id":"https:\/\/fronteraveracruz.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/fronteraveracruz.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/fronteraveracruz.com\/#organization","name":"Frontera Veracruz","url":"https:\/\/fronteraveracruz.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/fronteraveracruz.com\/#\/schema\/logo\/image\/","url":"https:\/\/fronteraveracruz.com\/wp-content\/uploads\/2026\/06\/logo-header.png","contentUrl":"https:\/\/fronteraveracruz.com\/wp-content\/uploads\/2026\/06\/logo-header.png","width":600,"height":220,"caption":"Frontera Veracruz"},"image":{"@id":"https:\/\/fronteraveracruz.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/share\/1CtNrbq7Bz\/"]},{"@type":"Person","@id":"https:\/\/fronteraveracruz.com\/#\/schema\/person\/bcc4f8719847e210f67a9030f3486609","name":"admin","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/ee9bf24b351129017c91674dc617cfdc21c62b9b23a52c046f0b2543ba35355c?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/ee9bf24b351129017c91674dc617cfdc21c62b9b23a52c046f0b2543ba35355c?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ee9bf24b351129017c91674dc617cfdc21c62b9b23a52c046f0b2543ba35355c?s=96&d=mm&r=g","caption":"admin"},"sameAs":["https:\/\/fronteraveracruz.com"],"url":"https:\/\/fronteraveracruz.com\/?author=1"}]}},"_links":{"self":[{"href":"https:\/\/fronteraveracruz.com\/index.php?rest_route=\/wp\/v2\/posts\/444904","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/fronteraveracruz.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/fronteraveracruz.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/fronteraveracruz.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/fronteraveracruz.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=444904"}],"version-history":[{"count":0,"href":"https:\/\/fronteraveracruz.com\/index.php?rest_route=\/wp\/v2\/posts\/444904\/revisions"}],"wp:attachment":[{"href":"https:\/\/fronteraveracruz.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=444904"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/fronteraveracruz.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=444904"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/fronteraveracruz.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=444904"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}